Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Grady

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Neuropharmacology|February 2, 2010
Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptorsSharon R Grady, Ryan M Drenan, Scott R Breining, et al.
Neuroscience|November 15, 2011
Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behaviorB N Cohen, E D W Mackey, S R Grady, et al.
Pharmacology, Biochemistry, and Behavior|November 6, 2012
Mice expressing the ADNFLE valine 287 leucine mutation of the Β2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor functionHeidi C O'Neill, Duncan C Laverty, Natalie E Patzlaff, et al.
Neuron|October 23, 2008
In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptorsRyan M Drenan, Sharon R Grady, Paul Whiteaker, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 3, 2007
Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant pathRaad Nashmi, Cheng Xiao, Purnima Deshpande, et al.
Frontiers in Pharmacology|October 17, 2017
TC299423, a Novel Agonist for Nicotinic Acetylcholine ReceptorsTeagan R Wall, Brandon J Henderson, George Voren, et al.
British Journal of Pharmacology|September 11, 2012
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessationMariaelvina Sala, Daniela Braida, Luca Pucci, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 28, 2012
α6* nicotinic acetylcholine receptor expression and function in a visual salience circuitElisha D W Mackey, Staci E Engle, Mi Ran Kim, et al.
The American Journal of Cardiology|March 2, 2017
Risk Estimates for Atherosclerotic Cardiovascular Disease in Adults With Congenital Heart DiseaseGeorge K Lui, Ian S Rogers, Victoria Y Ding, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2003
The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviorsChanghai Cui, T K Booker, Roberta S Allen, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Neuropharmacology|February 2, 2010
Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptorsSharon R Grady, Ryan M Drenan, Scott R Breining, et al.
Neuroscience|November 15, 2011
Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behaviorB N Cohen, E D W Mackey, S R Grady, et al.
Pharmacology, Biochemistry, and Behavior|November 6, 2012
Mice expressing the ADNFLE valine 287 leucine mutation of the Β2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor functionHeidi C O'Neill, Duncan C Laverty, Natalie E Patzlaff, et al.
Neuron|October 23, 2008
In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptorsRyan M Drenan, Sharon R Grady, Paul Whiteaker, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 3, 2007
Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant pathRaad Nashmi, Cheng Xiao, Purnima Deshpande, et al.
Frontiers in Pharmacology|October 17, 2017
TC299423, a Novel Agonist for Nicotinic Acetylcholine ReceptorsTeagan R Wall, Brandon J Henderson, George Voren, et al.
British Journal of Pharmacology|September 11, 2012
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessationMariaelvina Sala, Daniela Braida, Luca Pucci, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 28, 2012
α6* nicotinic acetylcholine receptor expression and function in a visual salience circuitElisha D W Mackey, Staci E Engle, Mi Ran Kim, et al.
The American Journal of Cardiology|March 2, 2017
Risk Estimates for Atherosclerotic Cardiovascular Disease in Adults With Congenital Heart DiseaseGeorge K Lui, Ian S Rogers, Victoria Y Ding, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2003
The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviorsChanghai Cui, T K Booker, Roberta S Allen, et al.
Pageof 16